Skip to main content
$38.50 $2.20 (6.1%)

04:00 PM EST on 01/20/22

Outset Medical, Inc. (NASDAQ:OM)

CAPS Rating: 5 out of 5

Current Price $38.50 Mkt Cap $1.8B
Open $36.94 P/E Ratio 0.00
Prev. Close $38.50 Div. (Yield) $0.00 (0.0%)
Daily Range $36.94 - $39.83 Volume 692,309
52-Wk Range $34.68 - $61.00 Avg. Daily Vol. 530,764

Caps

How do you think NASDAQ:OM will perform against the market?

Add Stock to CAPS Watchlist

All Players

61 Outperform
0 Underperform
 

All-Star Players

12 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:OM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:OM VS S&P 500 (SPY)

NASDAQ:OM Summary

Fools bullish on NASDAQ:OM are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about OM.

Recs

0
Member Avatar Winstin (< 20) Submitted: 10/8/2021 2:29:11 PM : Outperform Start Price: $48.24 NASDAQ:OM Score: -21.93

A disruptor in it's field. Strong fundamentals and a great product.

Recs

0
Member Avatar JerseyJester (< 20) Submitted: 8/28/2021 11:11:15 AM : Outperform Start Price: $45.35 NASDAQ:OM Score: -21.03

Outset Medical aspires to write the next chapter in dialysis, reducing the cost and complexity of this essential service. The Tablo dialysis system is FDA approved for both hospital and home use, reducing the size and incorporating water purification and on-demand production of dialysate. This creates a portable system with integrated analysis to provide dialysis anytime, anywhere, by anyone.

Recs

0
Member Avatar Thwack (33.99) Submitted: 8/28/2021 4:38:04 AM : Outperform Start Price: $45.52 NASDAQ:OM Score: -14.45

What they do is the dialysis of tomorrow, simple, affordable, reliable, replacing the existing complex, expensive systems today. In Australia (where I am from) most health insurance plans simply dont cover dialysis - its too expensive. But the need for dialysis is growing - we have an expanding population with expanding waistlines.. Outset medical should succeed here, and I want them to succeed as it should result in a major cost reduction for the provision of dialysis and so it should then become a standard inclusion in health insurance plans.

The upside for O.M is huge, the dialysis market is huge, and they seem to have some moat here. Add to this the last 3 quarters showing some operating margin coming into play and its a top pick for me.

Leaderboard

Find the members with the highest scoring picks in OM.

Score Leader

eruiz285

eruiz285 (48.24) Score: +33.64

The Score Leader is the player with the highest score across all their picks in OM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
didoman 20.17 8/17/2021 Outperform 5Y $37.92 +1.53% +0.75% +0.78 0 Comment
Itsnottoolate < 20 8/13/2021 Outperform 5Y $38.22 +0.75% +0.27% +0.47 0 Comment
Car12703 < 20 8/16/2021 Outperform 5Y $38.63 -0.34% +0.59% -0.93 1 Comment
Wakanda 99.56 8/16/2021 Outperform 5Y $38.74 -0.62% +0.51% -1.13 0 Comment
MEExpat 39.29 8/16/2021 Outperform 5Y $38.74 -0.62% +0.51% -1.13 0 Comment
TMFEdyboom223 91.48 8/16/2021 Outperform 5Y $38.74 -0.62% +0.51% -1.13 0 Comment
StockBeagle79 38.28 8/16/2021 Outperform 5Y $38.74 -0.62% +0.51% -1.13 0 Comment
tubogoo < 20 8/16/2021 Outperform 5Y $39.08 -1.48% +0.79% -2.27 0 Comment
askatch < 20 12/16/2021 Outperform 5Y $44.71 -13.89% -4.70% -9.19 0 Comment
FoolsSaidI 99.94 12/23/2021 Outperform 5Y $45.50 -15.38% -4.69% -10.70 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for OM.